Comparison Between 2 Techniques for Lumbar-ESPB

NCT07104097 — Not applicable, Completed, 44 participants, Papa Giovanni XXIII Hospital

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Regional Anesthesia in Hip Arthroplasty- Comparison Between Two Techniques for Erector Spinae Plane Block

RegistryNCT07104097, acronym ESPTA
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: single, treatment
Enrollment44 (Actual)
SponsorPapa Giovanni XXIII Hospital (Other)
ConditionsHip Surgery
Interventionsspinal anesthesia, superficial erector spinal plane block (ESPB), deep (inter laminar) erector spinal plane block (ESPB), Dexamethasone, Ibuprofen 400 mg, Paracetamol, Morphine (Procedure, drug)
Datesstart 2025-10-06, primary completion 2026-06-30, completion 2026-07-02, first posted 2025-08-05, last updated 2026-08-25
Locations1 site in Italy

Related Papers Related Patents Related Grants Related Experts
All trials for Hip Surgery All trials of spinal anesthesia All trials of superficial erector spinal plane block (ESPB)

-Summary

Diffusion of local anesthetics after a lumbar ESPB within fascial planes towards nerve structures is a matter of debate.

The main objective of the study is to compare the incidence of sensory block between two techniques of needle placement (superficial or translaminar) during lumbar ESPB block.

Patients are treated with lumbar ESPB (randomized to superficial or translaminar), spinal anesthesia and multimodal analgesia.

The primary endpoint will be the incidence of numbness/reduced skin sensitivity to cold (ice test) in the area innervated by the lumbar plexus. Secondary outcomes are pain and analgesic's consumption, motor block, quality of recovery and discharge ability.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
superficial ESPBActive comparatorProcedure: spinal anesthesia; Procedure: superficial erector spinal plane block (ESPB); Drug: Dexamethasone; Drug: Ibuprofen 400 mg; Drug: Paracetamol; Drug: MorphineInjection on top of L3 transverse process, plane between bone and erector spinae muscle
deep ESPBExperimentalProcedure: spinal anesthesia; Procedure: deep (inter laminar) erector spinal plane block (ESPB); Drug: Dexamethasone; Drug: Ibuprofen 400 mg; Drug: Paracetamol; Drug: MorphineInjection BETWEEN L3 and L4 transverse process, fascial plane between erector spinae muscle AND the deep muscles
  • spinal anesthesia (Procedure): spinal anesthesia at L3-L4 plain bupivacaine 0.5% 2.2 ml
  • superficial erector spinal plane block (ESPB) (Procedure): Lidocaine 1% + ropivacaine 0.25% 30 ml with adrenaline 1:200.000 on top of L3 transverse process, between bone and erector spinae muscle
  • deep (inter laminar) erector spinal plane block (ESPB) (Procedure): Lidocaine 1% + ropivacaine 0.25% 30 ml with adrenaline 1:200.000 between L3 and L4 transverse process, between erector spinae muscle and deep muscles
  • Dexamethasone (Drug): 8 mg iv preoperatively
  • Ibuprofen 400 mg (Drug): preoperatively and postoperatively (every 8 hours)
  • Paracetamol (Drug): 1000 mg preoperatively and postoperatively (every 8 hours)
  • Morphine (Drug): Patient Controlled Analgesia

+Outcome measures

Primary outcomes

  • sensory block [24 hours]: incidence of reduced or abolished cold sensation on the skin in the territory of lumbar plexus (anterior, medial and lateral thigh)

Secondary outcomes

  • motor block [24 hours]: block of extension and/or adduction of the thigh
  • postoperative pain [48 hours]: numeric rating scale - NRS 11 point scale from 0 = "no pain" to 10 = "worst imaginable pain"
  • morphine consumption [24 hours]: milligrams of morphine by patient controlled analgesia intravenously
  • quality of recovery [48 hours]: QoR-15 (Quality of Recovery 15 items) questionnaire - global measure of postoperative recovery, with a score ranging from 0 (extremely poor) to 150 (excellent)
  • complications [48 hours]: presence of nausea and vomiting, any other complication
  • discharge ability [48 hours]: PADDs score (Post Anaesthetic Discharge Scoring System) - 5 items, each scored from 0 to 2, where the higher the score (from 0 to 10), the greater the degree of the patient's recovery and readiness to be discharged. Scores of 9 or 10 mean the patient can be safely discharged.

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* primary total hip replacement
* informed consent

Exclusion Criteria:

* allergies to study drugs
* spinal anesthesia contraindicated
* kidney failure (GFR<30)
* epilepsy, psychiatric disease, neurologic deficits
* revision surgery
* neuropathies in the lumbar area (tingling, hypoestesia, numbness, motor deficit)
* no informed consent
* pregnancy
* alcohol/opioid abuse
* emergency surgery/intensive care

+Locations (1)

FacilityCityCountryStatus
Aast Papa Giovanni XxiiiBergamoItaly